FDA Import Refusal AEK-5452645-2/21/1 — ASTRAZENECA COLOMBIA
The FDA refused shipment AEK-5452645-2/21/1 from ASTRAZENECA COLOMBIA (Colombia) on Jul 3, 2024. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jul 3, 2024
- Country
- Colombia
- Product Category
- Drugs and Biologics
- Product Code
- 61PDY70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75